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Introduction to the DNP Practice Inquiry Project
In 1967 Dame Cicely Saunders opened the first hospice in London pioneering the
theories and practice of pain control in the dying patient.1 Since then, the modern hospice and
palliative care movement has flourished worldwide. The delivery of palliative care is achieved
through an interdisciplinary approach to treat the physical, psychosocial and spiritual dimensions
of patients and families living with a serious illness. Palliative care can occur at any stage in the
disease trajectory, from the point of diagnosis up until the end of life. The Clinical Nurse
Specialist (CNS) is uniquely prepared to reshape existing paradigms for health care delivery and
contribute meaningfully to the expansion of the specialty of hospice and palliative care. This
practice inquiry project applies the CNS conceptual model describing the three spheres of
influence to the hospice and palliative care practice setting.
The conceptual model for CNS practice describes three spheres of influence: the
patient/family, nurses and nursing practice, and organizations/systems. In the 50 years since the
development of the specialty, the role of the CNS has evolved to address the changing needs of
patients along the healthcare continuum, systems delivery models, educational preparations, and
the scientific and theoretical underpinnings of outcomes based nursing practice.2 National
Association of Clinical Nurse Specialists states the CNS prepared at the doctoral level will be
equipped with additional skills and competencies to advance healthcare and the nursing
profession through the evaluation and translation of evidence based practice, utilization of
theories and models from a variety of disciplines, improvement of quality of care and safety, and
providing the kind of leadership which fosters the interprofessional communication necessary to
make these transformational changes.3
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The following describes the DNP project I implemented and the synthesis of my program
of inquiry to fulfil the DNP degree requirements at the University of Kentucky. The first
manuscript focuses on the organizations/systems sphere of influence and is an integrative review
of the literature describing current practice and recommended standards for the care of patients
with implantable cardioverter defibrillators at the end of life in adults. The second manuscript
focuses on nurses, the nursing profession and the patient/family sphere. This manuscript
describes the adoption of an evidence-based bowel protocol for standing orders in a home
hospice environment utilizing the chronic care model as a framework. The final manuscript
focuses on the patient/family sphere and describes a study to assess perceptions of palliative care
among patients with serious illness in the acute setting utilizing a video enhanced educational
intervention.
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Abstract
Background: Active implantable cardioverter defibrillators (ICDs) have the potential to
decrease quality of life patients with terminal cardiac diagnosis at the end of life. The informed
consent process prior to device placement should include both short and long term goals as well
as consequences of ICD implantation. Often, these ramifications may not be consistently
discussed or understood by patients. The purpose of this paper is to conduct an integrative review
of the literature to examine the knowledge, attitudes, and perceptions of ICD deactivation and
end of life issues among ICD recipients. Methods: PubMed was searched using the key words 1)
“implantable cardioverter defibrillator” AND “end of life” AND “adult”. Eligible studies were
published within the last five years, written in English, and were specific to patient attitudes,
knowledge and perceptions of ICD deactivation at the end of life. Result: Patients are likely to
have insufficient knowledge regarding ICD deactivation, and a minority of them recall receiving
information about deactivation from their healthcare provider prior to implantation. Patients with
ICDs are less likely to have advance directives in place. Among those that do, these advance
directives rarely address ICDs specifically. Discussion: Although the literature suggests rate
discussions with their health care providers regarding ICD deactivation as important, they
continue to demonstrate unrealistic expectations regarding the life prolonging potential of ICDs
when considering decision making at end of life. Conclusion: The rigorous nature of ICD
monitoring provides many opportunities to increase the amount of patients with advanced
directives and is consistent with expert recommendations by both the Heart Rhythm Society and
the European Heart Rhythm Society.

Key words: implantable cardioverter-defibrillator, end of life care, palliative care
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Knowledge and Perceptions of Implantable Cardioverter Defibrillator Deactivation at the End of
Life in Adults: An Integrative Review
Implantable cardioverter defibrillator therapy (ICD) is indicated for primary and
secondary prevention of sudden cardiac death with measures of left ventricular ejection fraction
used to guide appropriateness of therapy. 1 For patients at risk of sudden cardiac death due to
ventricular arrhythmias, ICDs can monitor heart rhythm and provide pacing or defibrillation as
needed. 2 The American Heart Association 3 estimates that approximately 10,000 individuals are
implanted with an ICD each month. Despite these interventions, patients who avoid sudden
cardiac death will likely succumb to progressive worsening of underlying heart failure 4 or the
development of other progressive life-limiting illnesses. In 2010, approximately one in nine
death certificates (about 279,098 deaths) mentioned heart failure. Of these, about 57,757 were
directly attributable to heart failure. 5
Patients have unrealistic expectations of the ICD’s ability to prevent cardiac related
deaths, particularly those with a diagnosis of heart failure. 6 Extension of ICD therapy into the
end of life can have significant negative psychosocial and physical consequences for patients,
leading to diminished quality of death. 7,8 The progressive nature of terminal illnesses can
increase the likelihood of arrhythmia inducing conditions such as pain, electrolyte abnormalities,
hypoxia, sepsis, and worsening heart failure leading to an increased frequency of ICD shocks. 9
Episodes of shock can cause significant physical pain as well as psychological distress for the
recipient. 9 A survey of 900 hospice programs in the United States revealed that 97% had
admitted at least one patient with an ICD in the preceding year, with 58% of those reporting a
patient had received a shock during that time. 10 Device deactivation occurs late in the disease
course and is often prompted by acute hospitalizations with a majority of patients having their
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ICD deactivated in the last week of life. 11 There are legitimate concerns regarding the economic
consequences of prolonged aggressive therapies. The AHA reports that the total direct and
indirect costs of cardiovascular disease and stroke in the United States exceed $503 billion,
making these disease groups the number one driver of healthcare costs among any other
diagnostic group. 12
Purpose
The Institute of Medicine 13 report “Crossing the Quality Chasm: A New System for the
21st Century” mandates models of care which are patient-centered to achieve optimum quality
outcomes. According to this report, patient-centeredness occurs when providers collaborate with
patients to design plans of care which are in line with their needs, desires and level of
understanding. Consensus statements by the European Heart Rhythm Society 9 and the Heart
Rhythm Society 14 affirm that ICD deactivation is both ethically and legally permissible at the
end of life. These statements also reiterate the IOM mandate of patient-centered care delivery,
recommending that ongoing discussion regarding any cardiovascular implantable electronic
devices should begin prior to initiation of these therapies.
The existing literature suggests that provider practice and attitudes regarding end of life
issues for patients receiving ICD therapy may be mismatched. Notably, this phenomena has been
investigated during the informed consent process among electrophysiologists. 15,16 When asked,
physician providers have acknowledged the importance of discussing end of life issues with
patients15,17,18; however, examinations of medical records do not reflect this intention. 16 To
effectively translate the Heart Rhythm Society and European Heart Rhythm Society
recommendations into practice both sides of the patient-provider transaction must be understood
in order to identify opportunities with the highest likelihood of success. The aim of this
7

integrative review is to synthesize the literature describing the knowledge, attitudes, and
perceptions of ICD deactivation and end of life issues among ICD recipients.
Methods
In February 2014 PubMed was searched using the key words 1) “implantable cardioverter
defibrillator” AND “end of life” AND “adult” and 2) “implantable cardioverter defibrillator”
AND “end of life” AND “deactivation.” From these searches 133 articles were retrieved. After
first-stage screening of titles and abstracts 25 of these articles contained all of the search
qualifiers and were published within the last five years, and written in English. Next, secondstage screening was performed by reviewing the full text of the remaining articles. Excluded
articles included four studies of provider attitudes and practice regarding ICDs at end of life, five
case studies or expert recommendations and seven studies not specific to patient knowledge or
attitudes regarding ICD deactivation. Nine remaining articles were included in the final review
examining end of life issues in adult patients with ICDs (Figure 1.)
Results
Seven of the studies selected for data extraction utilized retrospective cross-sectional
correlational designs and two of the selected studies utilized qualitative methodologies (Table 1).
The two qualitative studies reviewed both involved patient interviews with a particular focus on
what patients recall of their pre-implantation conversations with their physicians regarding end
of life decision making or device deactivation. The retrospective cohort studies were able to
gather more specific data regarding quantifiable knowledge or attitudes pertaining to ICDs. Data
extraction from all of the selected studies revealed three phenomena of interest. First, a snapshot
emerged of patients’ current attitudes about end of life decision making specific to their ICDs.
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Second, a substantial amount of data regarding patient knowledge of their expectations, general
knowledge and ethical concerns emerged. Finally, data arose concerning a mismatch in patientprovider communication.
Current Attitudes
In the qualitative studies reviewed, patients described an awareness of the uncertainty
their diagnoses held for the future. Additionally they were able to describe some of their fears
surrounding the progression of their illness, 19 and reported a desire for quality of life over
quantity. 20 Patients tended towards optimism, focusing on the present and placing great
confidence in the ICD’s ability to prevent sudden cardiac death, without giving much
consideration to the potential for death due to other causes such as progressive comorbid illness
or the development of other life-limiting illness such as cancer.
Among the remaining seven studies, between 45.9% 21 and 86% 22 of patients reported
that they had not previously considered ICD deactivation at end of life. A telephone survey
conducted by Kirkpatrick and colleagues 22 found that among the minority of patients who had
considered this, 82% of them had not discussed their concerns with a healthcare provider. The
authors also reported that among the cohort of 278 patients who were interviewed in the
Kirkpatrick study, 62 (22%) believed the ICD should remain activated in the event of a do not
resuscitate order, 90 (32%) believed it should remain activated if the patient enters hospice, and
54 (20%) were uncertain. 22
Herman and colleagues 21 examined how patients’ prior experiences with ICD shocks
may affect their attitudes towards deactivation at end of life. In a sample of 112 participants from
an outpatient setting, 31 had received a shock after implantation of their ICD. The participants in
9

this group was correlated with an increased likelihood of hospitalization compared to those who
had not received prior shocks (1.21 vs 0.79 hospitalizations, p<0.05). Participants with prior
shock experiences indicated this had an adverse effect on their psychological status. This group
also felt they were insufficiently informed about the ICD compared to those with no prior shock
experience (r=-0.368, p<0.05). Cohabitation also seemed to play a role in patient attitudes
regarding their ICD. Patients who lived alone were more likely to report their willingness to
deactivate their device at end of life compared to those who did not live alone (r = -0.21, p
=0.025). 21
An alternate study conducted by Raphael and colleagues 23 examined the relationship
between patients’ prior experiences with ICD shocks and their preferences for device
deactivation or end of life discussions with their healthcare provider. Among a group of 54
individuals from an outpatient clinic in Boston, 25% of patients with prior shock were more
likely to consider ICD deactivation compared with only 3% of patients who had no prior shock
experience (p = 0.01). Of the 29 participants who had not received prior shocks, 24% did not
want to discuss end of life or deactivation with their healthcare providers. No differences were
found in New York Heart Association class, ejection fraction or time since initiation of ICD
between groups of patients who would consider deactivation and those who would not. In the
event of an ICD shock patients may be forced to confront a new reality with regards to their
health and well-being. The authors note that the incidence of an ICD shock may prompt a period
of opportunity for healthcare providers to revisit discussions about ICD therapy goals and the
possibility of device deactivation in the future.
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Patient Knowledge
Patients may have unrealistic expectations of ICDs with predominantly positive attitudes
noted towards ICD battery replacement and place great faith in the ability of ICDs to extend life.
19

In the largest study reviewed examining patient knowledge of ICDs, Stromberg and colleagues

24

analyzed written surveys from 3,067 ICD recipients from the Swedish ICD and Pacemaker

Registry. The authors found 29% of the sample had insufficient knowledge regarding their ICDs.
Within the group, men were more likely to have sufficient knowledge than women (72%, 65%;
p<0.001) and those less than 65 years old were more likely than those 65 or older to have
sufficient knowledge (84%, 65%; p<0.001). The authors also found that sufficient knowledge
was more likely if the following topics were previously discussed with a physician: battery
replacement (n = 1,250; 76% vs 68%; p<0.001); deactivation (n=420; 76% vs 71%; p<0.001);
and illness trajectory (n=1,080; 78% vs 67%; p<0.001). 24
These findings are reinforced by two smaller studies. The Pedersen group 25 noted that
31% of their sample of 294 Dutch patients did not know ICD deactivation was possible. Lower
rates were found by Raphael and colleagues, 23 who noted only 3% of their sample (n = 54)
could remember being informed of the potential for ICD deactivation at the time of consent.
Although 85% of this sample could remember discussing benefits of ICD therapy at the time of
informed consent, less than half were able to recall discussing risks or side effects.
Misinformation regarding the ethics of device activation was explored in two studies. In
the large national cohort study conducted by Stromberg and colleagues 24 the authors noted 28%
(n=796) of respondents believed deactivation to be the same as euthanasia. Those in this
category were more likely to be older (68±11 vs 65±12; p<0.001), female (31% vs 26%;
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p<0.001), with lower education (42% ≤9 years vs 58% education >9 years; p<0.001), low quality
of life scores (0.793 vs 0.828; p<0.001), and also had symptoms of depression (36% vs 26%;
p<0.001) and anxiety (33% vs 25%: p<0.001). The study conducted by Kirkpatrick and
colleagues 22 noted 26% (n=71) considered deactivation synonymous with physician assisted
suicide, and 8% (n=23) as unsure. The authors did note a downward trend in these rates over the
data collection period between 2009 and 2010 which may have been attributable to spikes in
media attention towards palliative and end-of-life issues in response to U.S. health care reform.
Patient-Provider Communication
As alluded to earlier in this review, relatively few patients report having spoken to their
physicians about ICD management at end of life. Among a sample of 278 participants, the
Kirkpatrick group 22 found that 71 (26%) had a living will, seven (3%) had a healthcare power of
attorney and 62 (22%) had both. Kirkpatrick and colleagues 22 also reported that having an
advanced directive was significantly associated with age; they reported those with advanced
directives had a mean age 65 years compared to a mean age of 57 years among those without
advanced directives (p<0.0001). No other characteristics were associated with those who had
advanced directives versus those who did not. Most striking is that among this same group only
three (2%) participants had an advanced directive which specifically addressed their ICD. Most
(n = 267, 96%) had never discussed ICD deactivation at the end of life with a physician. 22]
Herman and colleagues 21 noted similar trends in their sample of 112 participants with 45.9%
(n=50) reporting that they had not thought about ICD deactivation at the end of life and only
7.3% (n=8) reporting prior discussions with their physician regarding ICD management at end of
life.
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Only one study examined demographic characteristics of patients with advanced
directives. These patients tended to be older at the time of implantation (69 years vs 60,
p<0.001), white (97% vs 90, p<0.02), and living local to a large center in Minnesota (14% vs
5%, p = 0.004). 26 With regards to primary diagnosis, patients with an advanced directive in
place were likely to have renal insufficiency (40% vs 26%, p = 0.005), COPD (32% vs 45%,
p<0.02), cancer (36% vs 54%, p=0.02) and dementia (4% vs 1%, p=0.03) than patients who did
not have an advanced directive in place. Even in instances where patients had an existing advanced
directive, this did not consistently increase likelihood of deactivation. Of 44 patients who died
during this study period, only two patients’ advanced directives specifically mentioned ICD
management. Additionally, ICD deactivation occurred for only seven patients (16%) at the end
of life. This finding suggests that a clear understanding of patient goals and preferences with
respect to the management of their ICDs at the end of life is not occurring between patients and
their healthcare providers.
General knowledge of advanced directives was addressed in a study conducted by Habal,
and colleagues. 27 In their sample of 41 participants from an ambulatory setting in Ontario 31
(76%) did not know what advanced directives were. Of 19 patients with an ICD, only two (11%)
reported discussing ICD deactivation with a physician. After patients were educated on the
natural course of heart failure, nine (47%) stated they would like deactivation of defibrillator if
their condition became worse, five (26%) would not want it deactivated, three (16%) were
unsure, and two (11%) did not answer.
Patient preferences for the timing and methods of end of life discussions were examined
in two studies. Eighty four percent of a sample population of patients with ICDs surveyed by the
Pedersen group 25 believed providers should inform them of the possibility for deactivation, and
13

62% of these expressed a preference to be informed orally and in writing. Roughly half (49%) of
these patients also reported beliefs that end of life discussions should occur before ICD therapy.
The Rapheal group 23observed a similar finding in a sample population of 54 patients with ICDs,
with 54% of these individuals expressing a preference for end of life discussions prior to device
implantation. In contrast the Kirkpatrick group 22 reported patient preferences for advanced
directive discussions at ICD follow up visits (n = 95, 34%) and end of life (n = 110, 40%) versus
at the time of device implantation (n = 44, 16%).
Several other factors have been reported which reflect patient preferences for provider
communication regarding provider discussions about end of life decision making specific to ICD
management. The Pedersen group 25 observed patient preferences for these conversations when
life expectancy is decreased (55%), before battery replacement (17%), and during the dying
process (26%). Patients responded they preferred these conversations initiated by their
electrophysiologists (n = 83, 31%), cardiologists (n = 126, 45%) or primary care physicians (n =
39, 14%). 22 Providers may be reluctant to initiate discussions with patients about ICD
management at the end of life, fearing these conversations may contribute to patient distress.
However, the Pedersen group (2013) 25 found that the majority of their participants believed
discussions would not increase anxiety in themselves (82%) or their families (68%) and that their
wish for worthy death at end of life was independently associated with favorable attitude toward
deactivation (or 2.14, 95% CI 1.49 to 3.06; p<0.0001).
Conclusion
The studies reviewed offer a more global insight into the knowledge, attitudes and desires
of patients with ICDs with regards to end of life decision making. It is likely that patients have
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insufficient knowledge regarding these issues. For patients receiving ICDs, informed consent as
well as end of life planning should be considered an ongoing process beginning at the initiation
of therapy and continuing through the disease process. Myths regarding the ethics of end of life
decision making coupled with unrealistic expectations of these devices to prevent all causes of
death persist. Patients without full understanding of these issues may be robbed of the
opportunity to make informed choices in line with their values or ideas of life quality or a “good”
death.
Although the potential for recall bias is high within several of these retrospective studies
which utilize participant interviews, the results do speak to the larger issues of informed consent
prior to initiation of therapy, and the frequency with which patients are encouraged to make their
desires for end of life through advanced directives, particularly directives which address
management of ICDs as applicable. The generalizability of the studies reviewed is one
limitation. Several studies in this review had relatively low sample sizes and did not routinely
include patients who were at the end of life. Additionally the largest sample of ICD recipients
studied was from Sweden 24, which may limit applicability to populations in other parts of the
world.
The Heart Rhythm Society 14 and the European Heart Rhythm Society 9 recommend
evidence based interventions promote advanced directive discussions including ICD specific
directives as standard practice. One quality improvement initiative implanted in a universityaffiliated non-for-profit hospice was able to increase the proportion of hospice patients who died
with a deactivated device by 27% through the implementation of ICD specific policies and
procedures, by making device and manufacturer information more readily accessible, making
deactivation magnets universally available, creating an ICD specific care plan, and improving
15

clinician and new-hire education. 28 Although this intervention shows promise for improving
quality of death, time can vary significantly between ICD implementation and end of life. The
consistent follow up and monitoring of all patients with ICDs during the treatment period 1
presents numerous opportunities to provide adequate information to patients regarding these
issues and this course of action is recommended by both the Heart Rhythm Society 14 and the
European Heart Rhythm Society. 9 Patient-provider communication and clinical interventions
can be enhanced in order to provide patients ample time to make informed decisions regarding
their devices and therapy at the end of life.
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Table 1
Summary of Included Studies
Author(s) (Year),
Level of Evidence

Design/Method

Purpose

Sample/Setting

Variables of
Interest

Findings

Significance

Fluur et al (2013),
level of evidence
VI

Grounded theory

Patient
perspectives on end
of life decisions at
time decision for
ICD intervention.

30 participants
from two ICD
referral centers
in Ontario. (24
accepted ICD; 6
declined ICD).

Quality versus
quantity of life.

Participant focus on avoidance
of sudden cardiac death; the
potential for death due to other
causes not considered by most
participants.

End of life issues
may not be
discussed fully prior
to ICD intervention.

37 patients with
ICDs for ≥6
months and not
in palliative
stage of terminal
illness from 5
Swedish
hospitals.

Being a part of an
uncertain illness
trajectory.

Predominant positive attitudes
towards ICD replacement;
unrealistic attitudes regarding
ICD to extend life.

Patients may have a
poor understanding
of disease trajectory.

Progressing from
one phase to
another.

Minority of participants said
they would make end of life
decisions in advance of need or
physical decline; few had
advanced directives in place
addressing the ICD.

Need exists to
discuss end of life
issues and promote
ICD specific
advanced directives
with patients who
have ICDs.

3,067 ICD
recipients
recruited from
the Swedish ICD
and Pacemaker
Registry

Knowledge in
relation to end of
life issues

29% with insufficient
knowledge. Men more likely to
have sufficient knowledge than
women (72%, 65%; p<0.001)

Large cross
sectional study in a
national cohort.

Strachan et al
(2011), level of
evidence VI

Stromberg et al (In
press) level of
evidence IV

Interview

Phenomenological
Interview

Cross-sectional
correlational
Written survey

ICD recipients
experiences with
ICD, battery
replacement and
end of life issues.

Describe
knowledge of ICD
therapy at end of
life among ICD
recipients; explore
patient-related
factors associated
with poor
insufficient ICD at
end of life
knowledge.
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Preferred mode of
death.
Technical realities
of ICD.

Standing at a
crossroads.

Symptoms of
anxiety and
depression
Quality of life

Age <65 years more likely than
age ≥65 years to have sufficient
knowledge (84%, 65%;
p<0.001).

Demographic and
clinical variables

Sufficient knowledge more
likely if previously discussed

Population subsets
at highest risk
include women,
older patients, less
educated, or with
symptoms of
anxiety/depression.

with physician battery
replacement (n = 1,250; 76% vs
68%; p<0.001); deactivation
(n=420; 76% vs 71%;
p<0.001); illness trajectory
(n=1,080; 78% vs 67%;
p<0.001).

Herman et al
(2013), level of
evidence IV

Cross-sectional
correlational
Written survey

Understand patient
opinions, attitudes,
wishes and
understanding of
ICDs at end of life.

112 participants
with ICDs from
an outpatient
clinic in the
Czech Republic.

Opinions,
attitudes, wishes
and understanding
of ICDs at end of
life (13 item
questionnaire)
Number of prior
shocks.
Diagnosis of
depression.

22

28% (n=796) who believe
deactivation is the same as
euthanasia were more likely to
be older (68±11 vs 65±12;
p<0.001), female (31% vs 26%;
p<0.001), lower education
(42% ≤9 years vs 58%
education >9 years; p<0.001);
low quality of life score (0.793
vs 0.828; p<0.001), with
symptoms of depression (36%
vs 26%; p<0.001) and anxiety
(33% vs 25%: p<0.001)
45.9% (n=50) had not thought
about ICD deactivation at end
of life; 7.3% (n=8) had
discussed ICD at end of life
with their physician.
No difference in questions
between those with
biventricular or nonbiventricular devices.

Indication for
ICD.

No significant difference
between patients with ICD for
primary or secondary
prevention.

Settings of ICD
and length of
therapy.

28% (n=31) patients had
received a shock and were more
likely to be hospitalized (1.21

40.1% indicated a
desire to be better
informed, however
only 7.3% of
participants reported
discussing ICD at
end of life with their
providers.
25.7% indicated a
refusal to discuss
deactivation at end
of life.
Highlights the
importance of
shared decision
making with regards
to information

vs 0.79 hospitalizations,
p<0.05). Of these, 8 (7.3%) had
received inappropriate shock.
Patients who “felt safer” were
less likely to consider
deactivation (r=-.245, p<0.05);
felt sufficiently informed
(r=0.2444, p<0.05); and had
discusses deactivation (r=0.3,
p<0.05).

sharing. However
patients may be
more receptive to
these discussions if
better informed.

Shocked patients indicated
adverse psychological
consequences, felt they were
insufficiently informed (r=0.368, p<0.05). Patients who
live alone more likely to
deactivate at end of life (r= 0.21, p =0.025). Those who
considered deactivation
indicated they would make the
decision without help (r=0.238,
p<0.05) .
Pedersen et al
(2013), level of
evidence IV

Cross-sectional
correlational
Written survey

Examine patient
knowledge and
wishes for ICD at
end of life
information.
Examine
prevalence and
correlations of
positive attitudes
towards
deactivation at end
of life.

294 patients
identified from a
medical center in
the Netherlands.
Three groups: de
novo implanted,
moderate
experience and
considerable
experience.
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Attitudes towards
deactivation.

31% did not know ICD
deactivation was possible.

Knowledge about
deactivation.

95% of participants believed
ICD patients should be
informed of the possibility of
deactivation.

Demographic and
clinical
characteristics.
Anxiety,
depression and
type-D
personality.

Trends for response
for or against
deactivation were
seen with anxiety.

62% believed patients should
be informed orally and in
writing.

Most patients do not
anticipate increased
anxiety in
themselves related
to end of life
discussions.

Participants believed
discussions should occur before
ICD therapy (49%), when life

Many patients may
be unaware that
ICDs can be

expectancy is decreased (55%),
before battery replacement
(17%), and during dying
process (26%).

deactivated at end of
life.

Participants believed
discussions would not increase
anxiety in themselves (82%) or
their families (68%).
246 participants (84%) could
make a choice for or against
deactivation. Patients less likely
to choose included recent ICD
(21%), moderate experience
(16%) than those with
considerable experience (10%)
(n.s.). Of the 246, 195 favored
deactivation.
Wish for high quality of death
independently associated with
favorable attitude toward
deactivation (or 2.14, 95% CI
1.49 to 3.06; p<0.0001).
Kirkpatrick et al
(2012), level of
evidence IV

Cross-sectional
correlational
Telephone survey

Not stated

278 patients with
ICDs extracted
from a
cardiovascular
implantable
electronic device
clinic in
Pennsylvania.

Number of
patients with
ICDs have
advanced
directives that
explicitly address
the ICD
Patient
preferences for
ICD handling
particularly at end
of life and in a
hospice setting.
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103 (38%) of participants had
been shocked (mean number of
shocks 4.69); 80 (30%) were
being followed by a palliative
care physician; 56 (20%) had a
cancer diagnosis.
71 (26%) had a living will; 7
(3%) had a healthcare power of
attorney; 62 (22%) had both.
Having an advanced directive
was significantly associated
with age (mean age 65 vs 57
years). No other associated

Patients desire
discussions
regarding end of life
decision making and
may prefer this
information from
their cardiologists or
electrophysiologists.

Belief that
deactivation is the
equivalent of
physician assisted
suicide.
Perspectives on
advanced
directives for
ICD.
Physician
preference for
ICD handling.

characteristics were noted.
Only 3 (2%) participants had an
advanced directive which
specifically addressed their
ICD.
Most (n = 267, 96%) had never
discussed ICD at end of life
with physician.
Most (n = 238, 86%) had not
considered ICD in the event of
serious illness. Of those who
had, 30 (82%) had never
discussed with a medical
practitioner.
11% (n = 28) stated would keep
ICD on at end of life; 110
(42%) were unsure. 26%
(n=71) considered deactivation
synonymous with physician
assisted suicide, 8% (n=23)
were unsure (trended
downward in 2010).

Tajouri, et al
(2012), level of
evidence IV

Cross-sectional
correlational
Retrospective
chart review

Determine
advanced directive
prevalence among
ICD recipients as
well as the

420 patients who
had ICD
implanted at the
Mayo Clinic in
Minnesota.
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Patients with
advanced
directive

264 (95%) believed patients
should have the chance to
complete an ICD specific
advanced directive. Most
believed advanced directives
should be initiated at follow up
visit (n = 95, 34%), at end of
life (n = 110, 40%) versus at
implantation (n = 44, 16%)
Patients with advanced
directives were older at time of
implantation (69 years vs 60,
p<0.001), white (97% vs 90,
p<0.02), and lived in Olmstead

Patients often
include general
information
regarding “lifesustaining”

frequency with
which advanced
directives address
ICD management
at end of life.

Group 1: ICD
present (n = 127)

Characteristics of
the advanced
directive

County (local), Minnesota
(14% vs 5%, p = 0.004).
Patient with advanced directive
likely to have renal
insufficiency (40% vs 26%, p =
0.005), COPD (p<0.02), cancer
(p=0.02) and dementia
(p=0.03).

Group 2: ICD
absent (n = 293)

treatments in their
advanced directive.
Further education is
need to clarify exact
goals of care.

Differences between patients
with ICD for primary or
secondary prevention with and
without advanced directive
were not significant.
Of 44 patients who died, ICD
was deactivated in 7 (16%).
advanced directive did not
increase likelihood of
deactivation.
Of the patients with an
advanced directive the majority
were completed 12 months
prior to implantation (83, 65%),
the fewest completed after
implantation (10, 8%)
Only 2 advanced directives
mentioned ICD or instructions
for end of life.
Habal, et al (2011),
level of evidence
IV

Cross-sectional
correlational
Prospective, semistructured
interviews

Determine HF
patients’
awareness,
understanding and
utilization of
advanced
directives.

41 participants
from an
ambulatory heart
function clinic in
Ontario.
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Demographics.
Awareness of
advanced
directives

31 (76%) did not know what
advanced directives were.
Of 19 patients with an ICD,
only 2 (11%) reported
discussing ICD deactivation
with a physician.

Patients require
additional
opportunities for
education in order to
make the most
informed decisions.

Knowledge of
resuscitation
options
Current
resuscitation
preference

Raphael et al
(2011), level of
evidence IV

Cross-sectional
correlational
Semi-structured
interview

Describe patient
understanding of
consent for ICD
intervention.

54 patients from
a tertiary heart
failure referral
center in Boston.

Determine attitudes
towards future
deactivation.

Group 1: (N=29)
ICD but no
shocks
Group 2: (N=25)
ICD for 6
months and at
least one shock

Recollection of
consent
Timing of
deactivation
discussions
Appropriate
situations for
device
deactivation
Option of variable
switch-off device.

After patients educated on
natural course of HF 9 (47%)
stated they would like
deactivation of defibrillator if
their condition became worse; 5
(26%) would not want it
deactivated; 3 (16%) were
unsure; 2 (11%) did not answer.
85% recall discussing benefits
at time of consent, less than
half recall discussing risks or
side effects.
3% remember being informed
the ICD could be deactivated at
time of consent, 38% report
becoming aware of potential for
ICD deactivation later.
24% of never shocked group
did not want to discuss end of
life.
84% believed ICD deactivation
should be discussed with
provider; 52% believed these
conversation should occur
before ICD intervention.

Levels of evidence: Melnyk and Fineout-Overholt29:
I.
Evidence obtained from a systematic review or meta-analysis of all relevant randomized controlled trials
II.
Evidence obtained from at least one randomized controlled trial
III.
Evidence obtained from well-designed controlled trials without randomization
IV.
Evidence obtained from well-designed case control and cohort studies
V.
Evidence obtained from systematic reviews of descriptive and qualitative studies
VI.
Evidence from a single descriptive or qualitative study
VII.
Evidence from opinion of authorities and/or reports of expert committees
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Discussions
regarding
deactivation should
take place prior to
initiation of ICD
therapy, and
reviewed after any
shock therapy.

Potentially relevant citations
identified from PubMed
(n = 133)
Excluded as not relevant to search
qualifiers, non-English language or
>5 years
(n = 108)
Included full text articles with
potential relevance written in English
within the last five years (n = 25)

Manuscripts included
(n = 9)
Qualitative studies: 2
Non-experimental cohort studies: 7

Figure 1. Study selection scheme
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Manuscripts excluded
(n = 16)
Provider attitudes: 4
Expert recommendations: 3
Consensus statements: 2
Not specific to patient
attitudes/knowledge about ICDs: 7

Manuscript Two
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Abstract
Background: Prevalence of constipation in home hospice patients has been estimated between
22% and 90%, with higher prevalence indicated when patients are self-reporting symptoms. The
Centers for Medicare and Medicaid Services are adjusting reimbursements for hospice services
based on the subjective experiences of symptom management among patients and their
caregivers. The purpose of this paper is to describe the process of a nurse led practice
improvement project to implement an evidence-based standing order set for constipation
management in a home hospice setting utilizing patient experience data as an evaluative
component. Methods: The steps of the Iowa Model for Evidence Based Practice Change were
utilized for this practice implementation project. Hospice CAHPS Survey data was monitored as
a proxy for intervention effectiveness. Results: Quarterly tracking and analysis of patient
experience data regarding constipation management provided ongoing and reflexive feedback
which was able to shape targeted interventions to improve outcomes. Discussion: As hospice
nurses begin to appraise and adapt the evidence for constipation management, such data can
prove useful in monitoring impact and adjusting practice accordingly to optimize outcomes.
Conclusion: The roles of nursing in shared governance committees, quality assurance and
performance improvement are complementary in the implementation of evidence based practice
changes and monitoring effectiveness.

Key words: Quality assurance; performance improvement; CAHPS; constipation.
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Adoption of an Evidence-Based Bowel Protocol for Standing Orders in a Home Hospice
Utilizing Patient Experience Data as an Evaluative Component
Home hospice organizations are instrumental in promoting patient centered care to
patients and families at the end of life. A fundamental aspect of quality hospice care is support of
patients and families through expert pain and symptom management. One study estimated 92%
of home hospice patients received an opioid during the last two months of their life 1. The role of
opioids in the development of constipation is well established and development of constipation is
further complicated by functional decline and disease progression. The reported prevalence of
constipation in palliative care populations varies with estimates between 22% and 90%2-4. One
study of patients admitted to specialized Palliative Care units in Sweden found the prevalence of
constipation varied depending on the definition used. A 7% prevalence of constipation was
observed when using a frequency-based definition versus a prevalence of 43% when constipation
was patient-reported.
The subjective experiences of patients and families is fast becoming a key component of
health care reimbursement. The Centers for Medicare and Medicaid (CMS) has led this shift with
their Value Based Purchasing Program, or “pay for performance” which utilizes weighted scores
for process and patient experience to determine reimbursement for hospitals. Similarly CMS has
responded to the mandate set forth from the Affordable Care Act of 2010 requiring hospice
programs submit quality data via the Hospice Quality Reporting Program5. The Hospice Quality
Reporting Program supports the Consumer Assessment of Healthcare Providers and Systems
(CAHPS) Hospice Survey to gauge the experience and satisfaction of hospice patients through
their identified informal caregivers6. There are several eligibility requirements for the hospice
CAHPS survey. The decedent must be at least 18 years of age and their death must have
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occurred at least 48 hours following their last hospice admission date. There must be a primary
caregiver on record in which to mail the survey and the caregiver has not previously declined to
be contacted. The caregiver of record must also reside within the U. S. or a U. S. Territory. All
surveys are administered by a third party CAHPS Hospice Survey vendor approved by the
Centers for Medicare and Medicaid and contracted directly from the participating hospice.
Caregivers for decedents of all payer sources and across all settings of hospice care (inpatient,
home, assisted living, nursing home) are eligible for participation7.
Conflicting and inconclusive evidence for the treatment of constipation among patients at
or nearing the end of life complicates best practice adoption and implementation. In any setting,
constipation is best treated through a patient centered approach which takes patients’
expectations into consideration as well as their perceptions of symptom burden8. Shared
governance councils are ideal vehicles for advancement of evidence based practice changes
within institutions 9. Improvements in professional engagement have been demonstrated by
evaluations of shared governance structures revealing that nurses feel their voices are
strengthened, that they are able to take ownership of the practice environment and that
interprofessional collaborations are promoted to solve complex clinical problems 10. The purpose
of this paper is to describe the process of a nurse led practice improvement project to implement
an evidence-based standing order set for constipation management in a home hospice setting
utilizing patient experience data as an evaluative component.
Methods
The Iowa Model of Evidence-Based Practice
The Iowa Model of Evidence-Based Practice as described by Titler and colleagues (2001)
provides the framework for identification of a relevant topic for clinical inquiry, team formation,
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appraisal and synthesis of the relevant best evidence, application of changes, evaluation and
dissemination. Step one involves identifying a problem-focused or knowledge-focused trigger
where an evidence based practice change may be needed. Second, the determination must be
made if the identified problem is indeed an organizational priority. Third, a team should be
assembled to develop the evidence based practice change. Fourth, the team must develop the
research question and then collect any relevant evidence in the literature. Fifth, the team must
critique and synthesize the research for use in practice. Sixth, after the team determines the
amount and quality of the available evidence is adequate an implementation plan is developed.
Seventh, once the practice is determined adaptable, the team may decide to make further
refinements or, if the change is appropriate for adoption it may be instituted. Eighth, the practice
change is then monitored through observation and analysis of structure, process and outcome
data. Finally, the results are disseminated 11,12.
Population and Setting
This evidence based practice improvement project occurred at a community-based,
hospital affiliated non-profit hospice organization in northern Kentucky between October 2015
and October 2016. The program serves patients in seven counties and cares for them in their
private residences, assisted living communities and long term care facilities. The program
maintains an average daily census of approximately 160 patients. Registered nurses responsible
for triage of phone calls after regular business hours began to notice a trend of increased patient
and family complaints of constipation with fecal impaction. Although standing orders for
management of constipation were available for registered nurses to initiate when clinically
indicated, they had not been updated to reflect changes in practice knowledge. These problem
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focused triggers initiated the evidence-based practice change cycle, prompting a review of
current practices, processes and protocols.
Data Collection and Analysis
At the next point in the Iowa Model, a decision must be made to determine if the problem
is an organizational priority. During monthly meetings of the of the home hospice unit based
design council the group worked collaboratively to determine this. In order to tease out possible
sources of the problem, a data tracking form was shared with after-hours hospice staff in order to
monitor patient and family reported incidence of impaction. Several communications were sent
to all nursing staff asking for participation in gathering this data. Thirteen incidents of impaction
were noted in an eight-week period. The most frequently cited comment reported was patient
medication non-adherence. During the same time period, the quality assurance and performance
improvement nurses began pilot implementation of quality measure data collection for the
Hospice CAHPS Survey. The unit based design council and the quality assurance and
performance improvement nurses identified two constipation related measures on the Hospice
CAHPS Survey to use as external benchmarks for measuring the success of planned practice
changes. The following questions were used: 1) While your family member was in hospice care,
did your family member ever have trouble with constipation; and 2) How often did your family
member get the help he or she needed for trouble with constipation. Responses were measured
on a four point Likert-type scale (“never”, “sometimes”, “usually”, “always”) with “always”
identified as the target response.
Process Implementation
The unit based design team working with the quality assurance performance
improvement nurses became the core team for the practice change. The team sought out and
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received the support of the nurse managers, hospice medical director and the collaborating
hospice pharmacist. All members of the team made themselves available to review and approve
any proposed changes. The unit based design team was then able to develop the research
question in order to collect and appraise the relevant evidence (Table 1).
The next step of the Iowa Model describes the development of an implementation plan.
After the evidence was synthesized and critiqued by the team, the standing order set for bowel
management was evaluated for consistency with current practice recommendations, evidence,
cost effectiveness and population need (Figure 1). Several changes were made to the order set
including the increasing the prn dose range for Senokot-S to reflect a maximum therapeutic dose
of one to four tabs twice daily; the addition of a Bisacodyl 10mg rectal suppository daily as
needed; and the addition of time-based parameters for the initiation of rectal interventions.
Recognizing the importance of continued staff education to coincide with the implementation of
the new standing order set, further refinements were made to the intervention. First, hospicespecific, evidence-based clinical reference material in the form of a computer based learning
module was made available to all nursing staff. Second, clinical information systems were
reviewed for their utility and ease of use. Specifically, the team reviewed the current electronic
medical record flowsheet for gastrointestinal assessment and collaborated to evaluate the
accessibility of the standing order set in the patient chart.
Results
Outcomes evaluation of the practice change includes monitoring and analysis of structure
and process data including environment, staff, cost and impact on the patient and family. The key
outcome measure determined by the workgroup became quarterly monitoring of the CAHPS
Hospice Survey. In the first quarter of Hospice CAHPS reporting this hospice met the national
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benchmark for total number of “always” responses to the questions “Patient received help for
constipation.” These results revealed additional opportunities for further improvement, including
improving perception of constipation management for hospice patients in nursing homes. To
follow up, the team began discussions with the unit team leader, a key member of the team
dedicated to education and practice improvement of the electronic medical record. The team
began to develop methods to extract additional evaluative reporting data include incidence of
rectal interventions and documentation of primary caregiver bowel management teaching.
Finally, dissemination of information including instruction and rationale for bowel regimen and
patient experience data tracking changes was shared during unit based design council meetings,
nursing team meetings. Additionally, the quality assurance and performance improvement nurses
maintained public bulletin boards reporting patient experience data.
Discussion
Bowel regimens are necessary as constipation can produce significant physical symptoms
for the terminally ill patient including pain, nausea and vomiting, rectal tears and bleeding,
bloating or abdominal distention, a sense of fullness and a sense of urgency 13. When untreated,
constipation can lead to increasingly severe complications including anorexia, dehydration,
abdominal pain, urinary retention or in severe cases, total bowel obstruction. Psychological
distress related to constipation and its symptoms can lead to poor quality of life for both the
patient and caregivers manifesting as anxiety, depression or agitation 3,14. Additionally, patients
may assign meaning to their worsening constipation and identify it as a sign of worsening
disease or health status 14. Planned interventions must take into consideration involvement of the
patient and caregiver to promote a patient centered approach which aligns all treatments with
patient goals, preferences and values. Many causes of constipation may not be easily reversible
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in the hospice patient as the progressive worsening of a life limiting disease often leads to a
compounding effect of causative factors 15.
Successful symptom management is a core service of any hospice program. The
importance of successful management of symptoms, particularly constipation is illustrated in the
patient experience data collection currently being implemented by the Centers for Medicare and
Medicaid Services. Although public reporting of the Hospice CAHPS Survey is not estimated to
begin until 2018, failure to comply with CMS submission guidelines for quality data results in a
2 point penalty for reimbursements, in effect creating a “pay for reporting” reimbursement
system5. Hospices which are early adopters of this quality reporting program have the
opportunity to strengthen programs which support the best possible patient outcomes while
simultaneously maximizing reimbursement potential for their programs.
Conclusion
Clavelle and colleagues (2016) have re-conceptualized shared governance as professional
governance and define it as “the accountability, professional obligation, collateral relationships
and decision-making of a professional, foundational to autonomous practice and achievement of
exemplary empirical outcomes.” (p. 310). In this example shared governance is a model
supportive of professional nursing practice which operates interdependently of management. 16.
Shared governance structures empower nurses to take ownership of practice patterns, improve
nursing care quality, maintain professional competence and act as stewards of nursing
knowledge through its creation and dissemination 12,16.
Evidence based nursing care lies at the intersection of best evidence, expert opinion and
the stated values, goals and preferences of patients and families. Interventions aimed at
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management of constipation by the hospice and palliative care nurse must continuously be
evaluated through the lens of patient and caregiver perceptions of care to achieve patient
centered care. Continued innovation is needed in the realms of research and performance
improvement to arrive at improved interventions and prevention strategies for the management
of constipation in populations nearing or at the end of life. Patient experience surveys create an
essential foundation to an emerging paradigm in healthcare where quality care with the patient at
the nucleus is incentivized. Hospice programs with robust frontline leadership teams in
collaboration with quality assurance and performance improvement teams will be best prepared
for the transition to increased transparency via public reporting programs. Perhaps more
importantly hospice programs with this framework in place will increase their organizational
agility by quickly identifying related patterns in patient and family reported experiences and
clinical outcomes and responding accordingly.
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Table 1
Summary of Evidence
Author(s),
Year
Abernathy et al.
(2003)17

Design/Model
Review

Andrews &
Morgan
(2013)18

Expert
recommendation

Candy et al.
(2015)15

Meta-analysis of
seven RCTs involving
616 participants

Clark &
Currow (2013)4

Systematic review of
20 articles examining
treatment of
constipation in a
hospice/palliative care
setting.

Hawley &
Byeon (2008)19

Nonrandomized, nonblinded sequential
cohort study

Purpose
Summary of palliative
management of GI
symptoms in advanced
cancer patients.
Improved assessment
and complex symptom
management can
enhance patient selfmanagement and
sense of control.
To evaluate the
effectiveness of
laxatives versus
methylnatrexone for
prophylaxis or
treatment of
constipation
To systematically
examine the definition
and primary outcome
measures used to
study constipation
among
hospice/palliative care
populations.
To compare the
effectiveness of
sennosides

Sample/Setting

Variables of Interest

Significance

NA

Nausea/Vomiting
Constipation
Diarrhea

NA

Assessment; contributing factors;
psychological impact; physiological
impact; treatment options; lifestyle
changes

616 patients with
advanced cancer
or other chronic
life limiting
illnesses.

Laxation, methylnaltrexone, lactulose,
senna, codanthramer, misrakasneham,
magnesium hydroxide with liquid
paraffin.

No clear superior
treatment for
constipation
management can be
established.

20 articles
examining
treatment of
constipation in a
hospice/palliative
care setting.

Primary outcomes varied and included:
laxation, bowel function, defecation-free
intervals of 72 hours, time to laxation,
number and types of laxatives,
constipation severity, average number of
bowel actions in the preceding three
weeks.

There is an unmet need
for a validated tool that
can be used to evaluate
constipation
consistently in the
literature.

60 Canadian
patients
hospitalized >5
days with a
cancer diagnosis:
30 docusate plus
sennosides
protocol

Sennosides only protocol produced
significantly more BM than sennosides
with docusate protocol (p<0.05).
Sennosides only group admitted for
symptom control and supportive care had
more BMs >50% of days compared to
sennosides plus docusate (62.5% vs
32%). More patients receiving sennosides

Sennosides only were
more effective at
inducing laxation. No
difference in incidence
of bowel cramps was
noted between groups.
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Constipation rates for
terminally ill cancer
patients between 5087%
NA

(control) versus
30 sennosides
only protocol
(intervention)
Librach et al.
(2010)20

Expert
recommendation

Larkin et al.
(2008)21

Expert
recommendation

Tarumi,
Wilson, Szafran
& Spooner
(2013)22

RCT

Thomas et al.
(2008)23

RCT

To define best
practices in
constipation
management for
patients with advanced
progressive illness.
To define best
practices in
constipation
management for
patients enrolled in
palliative care.
To assess efficacy of
docusate in hospice
patients.

NA

NA

74 patients from
three Canadian
inpatient hospice
units. (35
docusate group,
39 placebo
group).

To assess safety and
efficacy of
subcutaneous
methylnaltrexone in
palliative care patients
with opioid induced
constipation.
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plus doscusate received supplement of
lactulose, suppository or enema (57% vs
40%); cramping reported equally in both
groups; diarrhea more frequent in
sennosides only group (27% vs 13%)
Best practices include assessment,
physical examination, nonpharmacological interventions (toileting,
mobility, increasing oral intake if
appropriate) and pharmacological
interventions.
Treatment of constipation focused on
addressing the underlying cause. The use
of a stimulant laxative combined with a
softening agent is recommended.

No significant difference between the
sennosides and docusate group vs
sennosides alone.

While its role is limited
to treatment of opioid
induced constipation,
methylnaltrexone is
recommended to
improve sleep.
Data describing safety
and efficacy of
laxatives in a palliative
care population are
limited.
Addition of docusate to
bowel regimen should
carefully consider
continued assessment
findings, overall
medication burden and
patient preference.

OLD ORDERS

NEW ORDERS

•

Increase fluids and exercise as tolerated

•

Increase fluids and exercise as tolerated

•

Senokot-S tablets oral 1-2 tablets BID or
•

Senokot-S tablets 1-4 tablets BID OR

Miralax 17gm in 8oz fluid daily PRN

Miralax 17grams in 8oz fluid daily PRN
•

Administer Fleets, Soap Suds or Milk and
Molasses enema PRN

•

Bisacodyl 10mg rectal suppository daily
prn (no BM x3 days or PRN)

•

Administer fleets, soap suds or mineral oil
or milk and molasses enema PRN (no BM
>3 days or PRN)

Figure 1. Comparison between old and new standing orders
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Abstract
Background: Clear communication of the purpose and benefits of palliative care can reduce
barriers to acceptance of such services for patients and families. The purpose of this practice
improvement project was to assess and improve knowledge and perceptions of palliative care
among patients with a diagnosis of heart failure and cancer in the acute setting using a video
enhanced education intervention. Methods: This practice improvement project took place at a
555 bed teaching hospital. 18 patients referred to an inpatient palliative care consult service in
the acute care setting with a diagnosis of either heart failure or cancer participated. Result:
Paired sample t-tests were conducted to examine the effectiveness of the intervention in patients’
scores assessing level of palliative care awareness (Table 2). There was a significant positive
difference in the scores for level of palliative care awareness before (M = 2.56, SD = 1.25) and
after (M = 3.72, SD = 1.179) a five-minute video describing palliative care; t(17) = 3.82 p =
.001. Discussion: Video interventions delivered at the point of care in the acute setting may be
an effective tool for improving knowledge and perceptions of palliative care among patient with
diagnoses of heart failure or cancer. Conclusion: The benefits of video education may be
enhanced when delivered with the addition of face to face interaction by a member of the
healthcare team versus a video self-administered by the patient. Further evaluation is needed.

Key Words: palliative care; patient education; video enhanced education
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A Practice Improvement Project to Improve Knowledge and Perceptions of Palliative
Care among Patients with Heart Failure and Cancer in the Acute Setting Using Video Enhanced
Education
The World Health Organization1 defines palliative care as “…an approach that improves
the quality of life of patients and their families facing the problem associated with lifethreatening illness, through the prevention and relief of suffering by means of early identification
and impeccable assessment and treatment of pain and other problems - physical, psychosocial,
and spiritual.” Palliative care is a medical specialty that can be accessed for any individual living
with a serious illness and is appropriate for persons at any stage of a serious illness at any age.
Members of the palliative care team work alongside members of the patient’s primary care team
to provide an extra layer of support and assist in alleviating the symptoms, pain and stress of a
serious illness. Members of the palliative care team can help clarify patients’ and families’ goals
of care and assist in the alignment of prescribed medical treatments with these desires. Models
for palliative care delivery exist in both inpatient and outpatient settings.2
Palliative care continues to be a growing medical specialty due to multiple factors. In
particular, the impact on national health and overall disease burden among aging baby boomers
nation-wide is estimated to result in the rapid growth of persons aged 65 and older between 2010
and 2050. By the year 2050 the projected number of Americans aged 65 and older is 88.5 million
– effectively doubling the current size of this population.3 As the population continues to age the
incidence of persons living with a serious illness is estimated to increase correspondingly.
According to the Centers for Disease Control and Prevention the top three causes of death in the
United States in 2013 were heart disease (611,105), cancer (585,881) and chronic lower
respiratory diseases (149,205)4. Currently an estimated 80% of older adults are living with a
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chronic condition and an estimated 50% are living with at least two chronic conditions further
contributing to their influx into the acute and ambulatory settings.4
At the end of a serious illness trajectory the medical and nursing care that is delivered
becomes increasingly complex. Hospice care, which currently requires a physician certification
that an individual has six months or less to live, is a philosophy of care delivery which falls
under the umbrella of palliative care. Unfortunately “just in time” hospice utilization has been
ineffective in reducing resource utilization, with duration of hospice enrollment averaging 3 days
and often preceded by multiple transitions in care during the last months of life.5 One proposed
solution to the escalation of resource utilization at the end of a serious illness trajectory is to
increase the frequency of advanced care planning conversations with patients and families prior
to condition deterioration. These discussions are facilitated by expert palliative care clinicians
can elicit patient preferences for treatment at the end of life so that the care patients receive is in
line with their values, beliefs and informed decisions. Effective advanced care planning
conversations decrease resource utilization and aggregate health care costs 6-9 and have
demonstrated positive effects on caregiver-reported quality of death.8 In addition to enhancing
patient centered care through expertly managed advanced care planning, palliative care has been
associated with reduced patient suffering, improved symptom recognition, improved pain
management, improved quality of life and improved survival outcomes for oncology patients
receiving palliative care concurrent with curative treatments.10-14
Problem
A 2011 study commissioned by the Center to Advance Palliative Care created a snapshot of
public awareness, attitudes and perceptions of palliative care15 to provide a framework to
improve communication regarding the benefits and future direction of this specialty with
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consumers and policymakers. Data were collected from a national survey of 800 adults age 18 or
older to assess current palliative care knowledge. When asked, “How knowledgeable, if at all,
are you about palliative care?” the overwhelming majority of respondents reported they were
“not at all knowledgeable” about palliative care. After information was provided to patients
regarding palliative care using clear, understandable language, an increase in individuals’
willingness to incorporate palliative care into their medical care was observed. Among persons
who reported no prior knowledge about palliative care and were given the opportunity to gain an
increased understanding about it, 92% reported they would be likely to utilize palliative care
services if they or their families were confronted with a serious illness. Additionally, 92% of
these individuals believed that they should have access to palliative care in the hospital setting.15
During transitions in care, particularly as individuals move between outpatient to inpatient
settings, patient education becomes critical and should be a continuous intervention.16 It is likely
that inpatients admitted for treatment related to their serious illness are unaware that palliative
care services are available to them, and that this issue is further complicated by the fact that
healthcare providers may use the terms “palliative care” and “end of life care” or “hospice”
interchangeably. Educational interventions targeted at improving knowledge and understanding
of palliative care should include standardized messages which have been tested in order to best
dispel myths and eliminate the confusion which exists for patients as they learn to differentiate
between hospice and palliative care.15
Review of the Literature
Currently, multiple national and specialty-specific guidelines recommend early integration of
palliative care for patients with serious illness. For patients with advanced heart failure the
American Heart Association recommends involvement of the palliative care team prior to a
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patient reaching refractory end stage heart failure.17 For patients with advanced metastatic cancer
diagnoses, the early integration of palliative care is supported by the National Comprehensive
Cancer Network which cites uncontrolled symptoms, moderate to severe diagnosis or treatment
related distress, serious comorbidity, a life expectancy of one year or less, patient or family
concerns regarding any aspect of the disease course or related decision-making or the request of
patients or family members as indications for a palliative care referral.18 Similarly the American
Society of Clinical Oncology issued a provisional clinical opinion that palliative care should be
considered for any patient with metastatic cancer and/or a high symptom burden after a phase III
randomized controlled trial found increased survival benefit, improvement in symptoms,
improved quality of life, increased patient satisfaction and reduced caregiver burden when
palliative care was combined with standard anti-cancer therapy.14,19
Confusion, myths and fear persist among the public and health care providers alike regarding
how to best define palliative care. A review of the literature utilizing “palliative care” as a search
term returns a greater number of studies written about end of life or hospice issues than papers
examining the role of palliative care in a role supportive to active or curative treatments.20 The
Institute of Medicine’s 2014 report, “Dying in America: Improving Quality and Honoring
Individual Preferences Near the End of Life” identified key recommendations for improving
quality and patient-centered outcomes for individuals approaching the end of life including the
delivery of person-centered, family-oriented care and improved clinician-patient
communication.21 Communicating the key messages and goals of palliative care effectively
reduce barriers to patient participation in palliative care programs and is an essential step to
improving outcomes.
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Patients are able to make informed decisions reflecting their values, goals and beliefs when
they have accurate information about palliative care. One qualitative study explored public
awareness and perceptions of palliative care.22 When asked, patients in the study expressed the
importance of dispelling myths surrounding palliative care and that public education through TV
advertisements, posters and leaflets, and inviting cancer survivors to act as “ambassadors” to
educate others were valued educational strategies.22 Patients and families desire accurate
information which enables them to make educated decisions regarding their planned medical
care. This finding further supports the findings of the Center to Advance Palliative Care public
opinion study cited earlier.15
To date, the seminal Study to Understand Prognoses and Preferences for Outcomes and
Risks of Treatments (SUPPORT)23 is the largest study examining outcomes related to enhanced
communication between seriously ill patients and health care providers. No significant
improvements were noted in key outcome variables such as incidence and timing of written DNR
orders, physician knowledge of resuscitation preferences, ICU length of stay, and incidence of
mechanical ventilation or reduced hospital resource utilization as a result of a patient-physician
communication intervention. Interventions which address patient-physician communication
alone may not be enough to impact patient-centered outcomes for the seriously ill.
With the exception of the Center to Advance Palliative Care commissioned survey,
there are few contemporary studies exploring educational interventions to enhance palliative care
knowledge and awareness for patients. Additionally, a few recent studies have explored
opportunities during an acute hospitalization to provide education, which distinguishes the
difference between palliative care and hospice or end of life services. A video enhanced
educational intervention provides a unique opportunity to clarify the principles of palliative care
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for patients in the acute care setting and can be delivered by any member of the interdisciplinary
team. The purpose of this practice improvement project was to improve knowledge and
perceptions of palliative care among patients with a diagnosis of heart failure and cancer in the
acute setting using a video enhanced education intervention.
Methods
Design, Sample and Setting
The setting for this project was a 555 bed teaching hospital in Cincinnati, Ohio. The
palliative care service at this facility is composed of advanced practice nurses, registered nurses,
social workers, physicians and chaplains with expertise in palliative care. Consultations are
triggered on admission for all patients with a diagnoses of advanced metastatic cancer or
advanced (New York Heart Association Class III/IV) heart failure by the attending physician.
Activities of the palliative care service include advanced symptom assessment and management,
care coordination among multiple specialties, management and support of the spiritual, cultural
and emotional aspects of care, advanced care planning and expert communication of patient and
family goals of care to the entire healthcare team.
For the purposes of this practice improvement project, the target population was
composed of acutely ill inpatients with diagnoses of either advanced hematologic or solid tumor
cancer or advanced heart failure referred to the palliative care service. A portion of the
accessible population reported prior exposure to palliative care services at this facility from a
previous admission. As such, this subset of patients serves as a distinct comparison group with
patients with patients having no previous palliative care experience. Patients considered for
inclusion were adults 18 years of age or older, English speaking, inpatients referred to the
palliative care service with a heart failure or cancer diagnosis, able and willing to provide
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consent and participate voluntarily and able to respond verbally to the survey questions
administered. Permission was obtained from The Christ Hospital Institutional Review Board and
the University of Kentucky Institutional Review Board. Decisional capacity was determined by
successful completion of a six-item dichotomous (yes/no) screening tool prior to patients
providing consent to participate. Data collection occurred between April 1 and June 31, 2016. A
convenience sample of 18 patients was identified within the described population who met
inclusion criteria for recruitment into this practice improvement project.
Video Enhanced Education
A brief video was created by myself in collaboration with the palliative care team which
describes the concept and philosophy of palliative care as well as summarizes the palliative care
service available specifically at facility. All media utilized to create the video was obtained with
permission under a royalty free license. Stock audio media was provided by
TuneLight/Pond5.com and stock video footage was provided by Eldelik, Monkey Business
Images, Wavebreakmedia Ltd and Dreamstime.com. Recording of the narrative, editing and
production took place at the University of Kentucky Media Depot. The video was reviewed and
approved by the interdisciplinary palliative care team. The acute care hospital retains proprietary
rights to the video. The video script (Appendix A) was derived from “Brochure Guidelines” by
the Center to Advance Palliative Care and incorporates messaging guidance from public opinion
research.15 A video education format was favored for several reasons. Video-enhanced education
is a cost effective method of delivering information to inpatient populations. A video can be
easily delivered to the bedside on-demand and can be provided by the primary nurse, who may
be the first to identify patients who could benefit from palliative care.
Evaluation
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Descriptive demographic data collected includes patient age, gender, race, level of
education, employment status and marital status. Health related demographic data includes
diagnosis (cardiac or oncologic), previous contact or interaction with the palliative care consult
team, hospital visit type (planned or acute) and palliative performance scale score. Palliative
performance scale scores were extracted from the patient electronic medical record.
Level of awareness of palliative care was assessed utilizing a five-point Likert-type scale
whereby patients were asked to report “not any knowledge”, “only a little knowledge”, “unsure”,
“some knowledge” or “a lot of knowledge”. All patients were then asked to respond to ten
additional statements from a survey assessing palliative care knowledge. This survey reflected
the messaging recommendations by the Center to Advance Palliative Care utilizing a ten-item,
five-point Likert-type survey (“strongly agree”, “disagree”, “unsure”, “agree”, “strongly agree”).
The survey asked patients to rank the following items regarding inpatient palliative care:
Improves quality of life for patients; improves quality of life for families; provides
compassionate care; can help me manage my pain; can help me manage symptoms other than
pain such as shortness of breath or nausea; can be given along my regular (life-prolonging)
treatments for my condition; is made up of a team of doctors, nurses, social workers, chaplains
and pharmacists; can assist me with any spiritual or emotional concerns I have; provides an extra
layer of support for me and my family; will communicate with my primary doctor about my
condition. The survey and level of palliative care knowledge patient reported assessment were
administered at baseline and immediately after the video intervention to evaluate affective
learning.
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Procedure
Patients identified as eligible for inclusion were approached by the principle investigator.
The study’s purpose and protocol were explained in detail to the patient. Informed consent was
obtained and documented by the principle investigator. Upon giving their informed consent,
patients were given a content evaluation survey to assess their prior knowledge of palliative care.
Patients were then asked to view the educational video describing palliative care and the content
evaluation survey was repeated. All surveys were administered verbally by the principal
investigator. Data were managed using REDCap (Research Electronic Data Capture) electronic
data capture tools hosted at The University of Kentucky College of Nursing.24 REDCap is a
secure, web-based application designed to support data capture for research studies, providing 1)
an intuitive interface for validated data entry; 2) audit trails for tracking data manipulation and
export procedures; 3) automated export procedures for seamless data downloads to common
statistical packages; and 4) procedures for importing data from external sources24.
Data Management and Analysis
Descriptive statistics were used to summarize the demographic and clinical
characteristics of the patients. Paired t-tests were used to assess changes in palliative care
knowledge between baseline and immediate post intervention scores. Change scores were
calculated as the difference between the post-intervention and baseline scores for palliative care
knowledge. All data analysis was conducted using SPSS version 20 and an alpha level of 0.5 was
used throughout.
Results
Among 18 patients 10 (55.6%) were female and 14 (77.8%) were Caucasian. More
patients were admitted with a primary diagnosis of cancer (n=12; 66.7%) than heart failure (n=6;
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33.3%). A greater number of patients in the sample reported their admission as the first contact
with the palliative care team (n=12; 66.7%) than those reporting contact during a prior admission
(n=6; 33.3%) (Table 1).
Paired sample t-tests were conducted to examine the effectiveness of the intervention in
patients’ scores assessing level of palliative care awareness (Table 2). There was a positive
difference in the scores for level of palliative care awareness pre (M = 2.56, SD = 1.25) and post
(M = 3.72, SD = 1.179) video intervention; t(17) = 3.82 p = .001. Positive differences were also
noted for the following survey items before and after the video education intervention
respectively: “Palliative care improves quality of life for patients” (M = 3.78, SD = .73; M =
4.22, SD = .73; t(17) = 3.69 p = .002); “Palliative care improves quality of life for families” (M =
3.89, SD = .76; M = 4.22, SD = .65; t(17) = 2.92 p = .010); “Palliative care can help me manage
symptoms other than pain such as shortness of breath or nausea” (M = 3.50, SD = .79; M = 4.11,
SD = .90; t(17) = 3.72 p = .002); “Palliative care can be given along with my regular (lifeprolonging) treatments for my condition” (M = 3.89, SD = .68; M = 4.39, SD = .50; t(17) = 3.43
p = .003); “Palliative provides an extra layer of support for me and my family” (M = 3.83, SD =
.86; M = 4.28, SD = .75; t(17) = 3.06 p = .007); “The palliative care will communicate with my
primary doctor about my condition” (M = 4.00, SD = .69; M = 4.50, SD = .51; t(17) = 4.12 p =
.001); Overall, there was a statistically significant increase in total palliative care knowledge
scores pre video intervention (M=41.56, SD=6.64) and post video intervention (M=46.61, SD=
6.25); t(17) = 4.83, p < .0005. (Table 2). The mean increase in total scores was 5.06 with a 95%
confidence interval ranging from 7.26 to 2.85. The eta squared statistic (0.58) indicating a large
effect size.
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Discussion
Prior research supports our findings of the efficacy of video based interventions on
increasing knowledge related to disease. Frosch and colleagues compared a group of men aged
≥50 years of age who received education from a video about the risks and benefits of PSA
screening and found a video-based decision aid (n=112) was significantly more effective than
information presented via the internet (n=114) (t (221) = 4.07, P < .001), 25 reflecting results
similar to those found by these authors. This could be due to two reasons. First, the video
interventions in the Frosch group’s study and these authors’ intervention have the advantage of
being available at the point of care and were initiated in the health care setting where patients
were likely to be present to their current health concerns. Second, Frosch and colleagues suggest
that patients may prefer health information from reputable and trustworthy sources such as
directly from the healthcare provider in the acute care setting. A video delivered to palliative care
patients during an inpatient hospital stay may influence patient perceptions of the trustworthiness
of educational intervention however further evaluation is needed.
In another study conducted by Moonaghi and colleagues, attitudes related to diet and
fluid intake among 75 hemodialysis patients were assessed at four data points after face-to-face
and video educational interventions.26 The authors found no significant differences and equal
efficacy between face to face and video methods of education at baseline, two and four weeks
post intervention (face to face: respectively; p < .001, p < .001, p <.001; video: p < .001, p <
.001, p = .001). It is important to note that when these authors delivered the palliative care video
education, encounter times with patients averaged about an hour. Often, the act of collecting
demographic data (asking patients’ if their admission was acute versus planned for example)
elicited historical narratives including details about recent treatments, complications, frustrations
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and hopes. It is possible that receiving the video intervention at the bedside with the opportunity
to ask questions and have a member of the healthcare team bear witness to the patient’s
experience is preferable to the delivery of a video that a patient self-administers or views
independently. Further research regarding the benefits of interventions which combine elements
of face to face and video enhanced teaching in palliative care populations is needed.
Generalizability of the results obtained from this practice improvement project to a larger
population is limited by the small sample size. In addition, a larger sample could have
illuminated differences in change scores associated with demographic elements of the sample.
However, by including patients with both heart failure and cancer this sample is representative of
those patients in the acute care setting who are most likely to utilize palliative care services. The
video and the survey used to assess palliative care knowledge were developed to ensure
consistency with tested language recommended by the Center to Advance Palliative Care.
Although consensus recommendations exist for inpatient palliative care programs, variation
among hospitals and regions exists between programs with regards to program maturity, staffing
and clarity of mission and vision. While the video includes material that is specific to the
palliative care program available at this facility, it does contain content based on national
recommendations and is reflective of the best evidence available for practice change in this
population.
Measures for health related quality of life and patients’ perceived involvement in care
were intended to be part of the final analysis, however these were incorrectly administered thus
invalidating the data. Inclusion of these measures could have provided further insight into
possible associations between any changes in palliative care knowledge and perceived
involvement in care or quality of life, particularly if these evaluations could have occurred in low
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up period of patients were discharged. Conducting research with palliative care populations
poses unique challenges. Patients eligible for palliative care consultation in a hospital setting are
by definition higher acuity with the potential for rapid changes in functional status and a limited
prognosis due to their advanced illness, limiting the feasibility of long-term follow-up.
Conclusion
The video as proposed is designed to be available to all inpatient nursing staff as an
educational aid for palliative care appropriate patients within the project setting. The video will
be made available in the patient education television channel, SkyLite. Utilizing this technology
allows the electronic medical record to be updated when the video is shown to a patient to
document the patient has received this education. This practice improvement project is
significant because it addresses common barriers in palliative care communication to patients
who are hospitalized in an acute care setting. Scripted communication fulfils the goals of
palliative care education to patients, families, and non-specialty members of the healthcare team
while simultaneously strengthening the messages presented by specialist team members.
Effective communication is an essential clinical tool in the palliative care professional’s arsenal.
As the palliative care specialty continues to define mission and vision and evolve its scientific
basis for practice a consistent presentation and clear message is needed to provide a clear picture
of what palliative care is, and what it is not to enable patients to make the difficult decisions
needed to receive the medical care they desire through the serious illness continuum.
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Table 1
Demographic Characteristics of Participant Sample
Variables

Frequency (n=18)

Percentage

< 65
≥ 65

11
7

61.1%
38.9%

Female
Male

10
8

55.6%
44.4%

4
14

22.2%
77.8%

3
12
3

16.7%
66.7%
16.7%

2
0
8
8

11.1%
44.4%
44.4%

12
6

66.7%
33.3%

12
6

66.7%
33.3%

5
13

27.8%
72.2%

6
12

33.3%
66.7%

0
3
6
6
3

16.7%
33.3%
33.3%
16.7%

Age

Gender

Race
Black or African American
White or Caucasian
Education
Some high school
Some college
Graduate degree
Employment status
Employed
Unemployed
Retired
Disabled
Relationship status
Married/partnered
Single/living alone
Primary diagnosis
Cancer
Heart Failure
Hospital visit type
Planned
Acute
Previous palliative care
contact
Yes
No
Self –reported health status
Excellent
Very Good
Good
Fair
Poor
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Table 2
Repeated Measures Data from Pre and Post Video Intervention Survey Scores

Level of palliative care
awareness
Quality patient care
Quality for families
Compassion
Pain management
Symptoms managed
Regular treatment
Team
Spiritual
Support
Communication
Total Score

Mean
(Pre and Post
Video)
2.56
3.72
3.78
4.22
3.89
4.22
4.22
4.39
3.72
4.17
3.50
4.11
3.89
4.39
4.11
4.39
4.00
4.22
3.83
4.28
4.00
4.50
41.56
46.61

Std. Deviation
(Pre and Post
Video)
1.25
1.18
.73
.73
.76
.65
.73
.78
.83
.86
.79
.90
.68
.50
.68
.61
.84
1.00
.86
.75
.69
.51
6.64
6.25
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t*

p (< .05)

3.823

.001

3.688

.002

2.915

.010

.825

.421

1.917

.072

3.716

.002

3.431

.003

1.567

.135

1.719

.104

3.063

.007

4.123

.001

4.832

<.0005

Conclusion
Professor of psychiatry and medicine at Harvard Medical School Susan Block states,
“Our main procedure in palliative care is difficult communication1 Indeed communicating
difficult information, whether related to the impacts of a life limiting illness, or urging nurses
and colleagues from other health care disciplines that changes in practice can achieve better
outcomes. The palliative care CNS is uniquely poised to impact change and improve patient care
outcomes in the palliative care specialty. The findings of this practice inquiry project illuminate
the potential impact of the DNP prepared CNS working to advance the palliative care specialty
through translation and implementation of practice changes within all three CNS spheres of
influence by acknowledging the interrelatedness of each aspect of the healthcare system.
The integrative review summarizing patient attitudes and knowledge about Implantable
Cardioverter Defibrillator deactivation creates a path for practice change within the
organizations/systems sphere of influence. Through critical appraisal and synthesis of the current
barriers to patient knowledge, the CNS can initiate the interdisciplinary dialogue needed to create
sustainable changes in practice that facilitate optimal palliative care delivery at the primary level
among generalist members of the healthcare team, as well at the secondary level, among
specialist palliative care providers. The second manuscript focusing on the nurse and nursing
sphere of influence describes the integration of best evidence into practice to optimize bowel
management for hospice patients. This is accomplished through the application of the Iowa
Model for evidence based practice integration and monitored utilizing national benchmarks to
evaluate effectiveness and to continue to identify new areas for improvement. Finally, the
implementation of a video enhanced education intervention illustrates the impact of the CNS at
the patient/family sphere of influence. Through the translation of existing research and expert
recommendations, a bedside intervention for seriously ill patients creates the opportunity to
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improve understanding of key palliative care concepts, thereby creating access to care by
reducing barriers created by misinformation and fear. The three spheres of influence model of
CNS practice acknowledges the interrelatedness of each aspect of the healthcare system. This
ultimately impacts current practices at the micro and macro levels and will be essential in driving
new and meaningful changes in a fragmented healthcare system.
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Appendix A
Palliative Care Script
If you are seriously ill, you should know that The Christ Hospital has a special program to help you during your
hospitalization. The Christ Hospital’s Palliative Care Service provides comprehensive and compassionate care
focused on relief of suffering and improvement of quality of life for patients and families coping with serious illness
while they are in the hospital. Palliative care is specialized medical care for people with serious illnesses. This type
of care focuses on relieving the symptoms, pain and stresses of a serious illness—whatever the diagnosis.
The goal of palliative care is to improve quality of life for both the patient and the family. Palliative care is provided
by a team of doctors, nurses and other specialists working in partnership with a patient, their medical specialists and
their family to provide an extra layer of support. Palliative care is appropriate at any age and at any stage in a serious
illness, and can be provided together with curative treatment.
Who is on the palliative care team?
The team is made up of physicians, nurses, chaplains, social workers and pharmacists experienced in palliative care.
They will work alongside the patient’s other doctors and healthcare providers.
What happens during a palliative care consultation?
A doctor and/or nurse who specializes in palliative care will review the patient’s records and speak with the patient’s
other doctors. Members of the team will meet with the patient and/or his or her loved ones to assess patient and
family needs. When appropriate, they will arrange a family care conference to discuss the patient’s medical issues,
options and goals of care. The team will document findings in the medical record and make recommendations for
treatment when necessary.
What types of treatment can be provided?
The palliative care team will provide care based on the unique needs of each patient. Patient and family involvement
is encouraged to foster a better understanding of the illness and goals of care.
• The palliative care team can address symptoms such as pain, trouble sleeping, shortness of breath, nausea,
weakness and other conditions causing discomfort.
• The team can coordinate care when several specialists are treating varying aspects of the patient’s illness.
• The team can assist with making daily physical activities easier and offer exercise and nutrition planning.
• Specialists in spiritual care and social work can address the spiritual, cultural and emotional aspects of care.
• Team members will support patients and families to ensure their goals of care are clearly understood and aligned
with the medical treatments offered, especially if the patient becomes unable to communicate his or her wishes.
• The team will assist patients, their families and the hospital staff to make plans for care upon discharge from the
hospital.
Is palliative care just another name for hospice?
Palliative care is often confused with hospice – which is care focused on comfort when life-prolonging treatments
are no longer helpful. Palliative care is different. Even patients who are expected to fully recover from a serious
illness may benefit from palliative care services, which can be provided alongside full life-prolonging treatments.
How are palliative care consultations requested?
A palliative care consultation requires a doctor’s order. If you believe that you or your loved one would benefit from
palliative care, you may ask your doctor to request a consultation. You may also receive more information by calling
the palliative care team at 513-585-4157.
Palliative care reflects The Christ Hospital’s commitment to patient- and family-centered care, which focuses on
treating patients and families with dignity and respect, information sharing, participation and collaboration. Through
this service, we hope to empower patients and families to make healthcare decisions with peace of mind.
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Appendix B
Level of Palliative Care Awareness Survey
1. Please rate your level of awareness of palliative care:
(1) Not any knowledge
(2) Only a little knowledge
(3) Unsure
(4) Some knowledge
(5) A lot of knowledge

Please answer the following questions regarding palliative care:
2. Palliative care improves quality of life for patients
(1) Strongly disagree
(2) Disagree
(3) Unsure
(4) Agree
(5) Strongly agree

3. Palliative care improves quality of life for families
(1) Strongly disagree
(2) Disagree
(3) Unsure
(4) Agree
(5) Strongly agree
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4. Palliative care provides compassionate care
(1) Strongly disagree
(2) Disagree
(3) Unsure
(4) Agree
(5) Strongly agree

5. Palliative care can help me manage my pain
(1) Strongly disagree
(2) Disagree
(3) Unsure
(4) Agree
(5) Strongly agree

6. Palliative care can help me manage symptoms other than pain such as shortness of breath or
nausea
(1) Strongly disagree
(2) Disagree
(3) Unsure
(4) Agree
(5) Strongly agree

7. Palliative care can be given along my regular (life-prolonging) treatments for my condition
(1) Strongly disagree
(2) Disagree
(3) Unsure
(4) Agree
(5) Strongly agree
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8. Palliative care is made up of a team of doctors, nurses, social workers, chaplains and
pharmacists
(1) Strongly disagree
(2) Disagree
(3) Unsure
(4) Agree
(5) Strongly agree

9. Palliative care can assist me with any spiritual or emotional concerns I have
(1) Strongly disagree
(2) Disagree
(3) Unsure
(4) Agree
(5) Strongly agree

10. Palliative care provides an extra layer of support for me and my family
(1) Strongly disagree
(2) Disagree
(3) Unsure
(4) Agree
(5) Strongly agree

11. The palliative care team will communicate with my primary doctor about my condition
(1) Strongly disagree
(2) Disagree
(3) Unsure
(4) Agree
(5) Strongly agree
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Appendix C
Center to Advance Palliative Care (2011) Key Messages
Key Messages
Key messages are essential tools for any kind
of communication with your audience. They
bridge what your audience already knows
with where you are trying to lead them. Your
key messages will change depending on the
topic or question you’re going to address.
Most of the time you will want to use no more
than three key messages.
The top messages below reinforce for the
public the goals of palliative care. They
address the topic/question “What is palliative
care? “
•

•

•

•

•

Palliative care helps to provide the
best possible quality of life for a
patient and their family.
Palliative care helps patients and
families manage the pain, symptoms,
and stress of serious illness.
Palliative care is a partnership of
patient, medical specialists, and
family.
Palliative care is appropriate at any
age and at any stage in a serious
illness and can be provided along with
curative treatment.
Palliative care provides an extra layer
of support for families and patients
with serious illness.

Definition of Palliative Care
The following definition should be used when
defining or describing palliative care for
consumers:
Palliative care is specialized medical care for
people with serious illnesses. This type of
care is focused on providing patients with
relief from the symptoms, pain, and stress of a
serious illness—whatever the diagnosis.
The goal is to improve quality of life for both
the patient and the family. Palliative care is
provided by a team of doctors, nurses, and
other specialists who work with a patient's
other doctors to provide an extra layer of
support. Palliative care is appropriate at any
age and at any stage in a serious illness, and
can be provided together with curative
treatment.
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